Effect of Platelet-rich Plasma (PRP) Injection on Knee Osteoarthritis
Recruiting · NCT06082531 · Interventional (participants receive a specific treatment) · Lead sponsor: Xijing Hospital
View the official record on ClinicalTrials.gov →Interventions studied
Sodium hyaluronate injection
What this trial is about
To evaluate the safety and effectiveness of PRP injection therapy in the repair of osteoarthritis and periarticular soft tissue injury through a single-center, exploratory clinical study, and to provide a more reliable basis for the treatment of joint injury.
Who can take part
Age range
20 Years to 60 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- The age range of the participants was 20 to 60 years old. Through a comprehensive clinical and imaging examination, it was conclusively determined that the individuals had knee osteoarthritis or experienced injuries to the cart, and meniscus surrounding the knee joint.
- The preoperative routine tests and examinations revealed no contraindications.
- Revised sentence: "Informed consent of the patient
Exclusion criteria
- The platelet count or function exhibits significant abnormalities、Systemic infection transmitted through the bloodstream.
- Prolonged usage of anti-inflammatory drugs and systemic corticoid administration.
- In injection site or damage to the skin.
- Patients with tumors or undergoing radiotherapy and chemotherapy.
- Pregnant or breastfeeding women.
- Individuals with mental illnesses who are unable to cooperate with follow-up procedures.
- Contraindications for MRI、Patients or their families do consent to participate in the study.
- Other circumstances that render participation in the study unsuitable.
Where it is running
1 location listed.
- Xijing Hospital - Xi'an, Shannxi, China